I don't understand this management.
They keep silent about
the issues stockholders care about. They do not tell us anything,
and I mean anything about their quest for financing of Ovadx
tests, their progress toward getting Ovadx or Parkinsons approval
with the FDA, and then they issue a 10k report which is absolutely
silent about the same issues.
And they are producing significantly less revenue without explanation.
The 10k is one of the most negative statements of operations
that I have encountered in my investing career of many, many
years.
I believe the stock will close tomorrow somewhere from 8 cents
to 12 cents a share.
stox56
Market Data 
Markets 
AI
